Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients Without Optimally Controlled asthma (REACT) Study [Corrigendum]
Cheng SL, Ho ML, Lai YF, et al. Drug Des Devel Ther. 2020;14:5441–5450.The authors have advised there is an error in the formatting of the paper title on page 5441, the title “Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticaso...
Saved in:
Main Authors: | Cheng SL (Author), Ho ML (Author), Lai YF (Author), Wang HC (Author), Hsu JY (Author), Liu SF (Author), Huang MS (Author), Lee CH (Author), Lin CH (Author), Hang LW (Author), Liu YC (Author), Yang KY (Author), Wang JH (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study
by: Cheng SL, et al.
Published: (2020) -
Effects of Budesonide and Fluticasone Propionate in Pediatric Asthma Patients
by: Lin-Yu Kuo, et al.
Published: (2010) -
Improvement of airflow limitation by fluticasone propionate/salmeterol in chronic obstructive pulmonary disease: what is the specific marker?
by: Keiichiro eAkamatsu, et al.
Published: (2011) -
New developed spectrophotometric method for simultaneous determination of salmeterol xinafoate and fluticasone propionate in bulk powder and Seritide® diskus inhalation
by: Ahmed Samir, et al.
Published: (2012) -
Novel Fluticasone Propionate and Salmeterol Fixed-Dose Combination Nano-Encapsulated Particles Using Polyamide Based on L-Lysine
by: Mohammad H. Alyami, et al.
Published: (2022)